Literature DB >> 19038619

Diagnostic tools for calculation of glaucoma risk.

Steve L Mansberger1, Felipe A Medeiros, Mae Gordon.   

Abstract

Risk calculators may simplify the management of ocular hypertension and glaucoma patients and provide evidence-based treatment. Risk calculators are not new to medicine. Medical providers use risk calculators to guide decision-making for the risk of a chromosomal abnormality in neonates, osteoporosis in postmenopausal women, and cardiovascular disease in adults. This article describes the current knowledge of risk calculators in ophthalmology. Clinicians should recognize that the current risk calculators do not include critical information guiding treatment such as life expectancy and patient's willingness to commit to years of eye drops. Overall, eye-care providers should consider the results of a risk calculator as supplemental information when treating an ocular hypertension or glaucoma patient.

Entities:  

Mesh：

Year:  2008        PMID： 19038619      PMCID： PMC5993711          DOI： 10.1016/j.survophthal.2008.08.005

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN： 0039-6257            Impact factor:   6.048


  12 in total

1.  Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.

Authors:  Anne L Coleman; Mae O Gordon; Julia A Beiser; Michael A Kass
Journal:  Am J Ophthalmol       Date:  2004-10       Impact factor: 5.258

2.  A population-based evaluation of glaucoma screening: the Baltimore Eye Survey.

Authors:  J M Tielsch; J Katz; K Singh; H A Quigley; J D Gottsch; J Javitt; A Sommer
Journal:  Am J Epidemiol       Date:  1991-11-15       Impact factor: 4.897

3.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Early Manifest Glaucoma Trial: design and baseline data.

Authors:  M C Leske; A Heijl; L Hyman; B Bengtsson
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

5.  The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator.

Authors:  Steven L Mansberger; George A Cioffi
Journal:  J Glaucoma       Date:  2006-10       Impact factor: 2.503

6.  Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.

Authors:  Steven M Kymes; Michael A Kass; Douglas R Anderson; J Philip Miller; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2006-06       Impact factor: 5.258

7.  Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.

Authors:  Mae O Gordon; Valter Torri; Stefano Miglior; Julia A Beiser; Irene Floriani; J Philip Miller; Feng Gao; Ingrid Adamsons; Davide Poli; Ralph B D'Agostino; Michael A Kass
Journal:  Ophthalmology       Date:  2006-11-07       Impact factor: 12.079

8.  A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.

Authors: 
Journal:  JAMA       Date:  1995 Nov 22-29       Impact factor: 56.272

9.  Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.

Authors:  Jing Liu; Yuling Hong; Ralph B D'Agostino; Zhaosu Wu; Wei Wang; Jiayi Sun; Peter W F Wilson; William B Kannel; Dong Zhao
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

10.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Authors:  M Cristina Leske; Anders Heijl; Mohamed Hussein; Bo Bengtsson; Leslie Hyman; Eugene Komaroff
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  10 in total

1.  Pattern electroretinogram progression in glaucoma suspects.

Authors:  Lori M Ventura; Iuri Golubev; William J Feuer; Vittorio Porciatti
Journal:  J Glaucoma       Date:  2013-03       Impact factor: 2.503

2.  Head-down Posture in Glaucoma Suspects Induces Changes in IOP, Systemic Pressure, and PERG That Predict Future Loss of Optic Nerve Tissue.

Authors:  Vittorio Porciatti; William J Feuer; Pedro Monsalve; Giacinto Triolo; Luis Vazquez; John McSoley; Lori M Ventura
Journal:  J Glaucoma       Date:  2017-05       Impact factor: 2.503

3.  Over-diagnosed glaucoma:possible consequences for patients and health care services.

Authors:  E Detorakis; E Symvoulakis
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

4.  A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.

Authors:  Carlos Gustavo De Moraes; Mitra Sehi; David S Greenfield; Yun S Chung; Robert Ritch; Jeffrey M Liebmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

Review 5.  [Differentiation of ocular hypertension].

Authors:  E M Hoffmann; J Lamparter
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

6.  Using filtered forecasting techniques to determine personalized monitoring schedules for patients with open-angle glaucoma.

Authors:  Greggory J Schell; Mariel S Lavieri; Jonathan E Helm; Xiang Liu; David C Musch; Mark P Van Oyen; Joshua D Stein
Journal:  Ophthalmology       Date:  2014-04-04       Impact factor: 12.079

7.  Macular retinal and nerve fiber layer thickness in early glaucoma: clinical correlations.

Authors:  Vassiliki Arvanitaki; Miltiadis K Tsilimbaris; Aristofanis Pallikaris; Ioanna Moschandreas; Evangelos Minos; Ioannis G Pallikaris; Efstathios T Detorakis
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Apr-Jun

8.  Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma.

Authors:  Javier Moreno-Montañés; Ana García-Nieva; Indira Aristeguieta Osio; Adriano Guarnieri; Antonio Morilla-Grasa; Marta García-Granero; Alfonso Antón
Journal:  Transl Vis Sci Technol       Date:  2018-11-30       Impact factor: 3.283

9.  A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management.

Authors:  Daniel Laroche; Kara Rickford; Elise V Mike; Liane Hunter; Ezekiel Ede; Chester Ng; John Douglas
Journal:  J Ophthalmol       Date:  2022-07-31       Impact factor: 1.974

10.  External Validation and Clinical Applicability of Two Optical Coherence Tomography-Based Risk Calculators for Detecting Glaucoma.

Authors:  Néstor Ventura-Abreu; Marc Biarnés; Sofia Batlle-Ferrando; María Teresa Carrión-Donderis; Rafael Castro-Domínguez; María Jesús Muniesa; Elena Millá; Javier Moreno-Montañés; Marta Pazos
Journal:  Transl Vis Sci Technol       Date:  2022-07-08       Impact factor: 3.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.